ACA
MEDP icon

Atlas Capital Advisors’s Medpace MEDP Stock Holding History

Atlas Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Buy
+1,110
New +$512K 0.06% 249

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Atlas Capital Advisors's MEDP Position: Q2 2026 in Review

Atlas Capital Advisors opened a new position in Medpace (MEDP) in Q2 2026: 1,110 shares worth $588K. The stake represents 0.06% of the portfolio and ranks #249 among its holdings.

694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Atlas Capital Advisors held 1,110 shares of Medpace worth $588K as of Q2 2026.
  • Medpace was a new Atlas Capital Advisors position in Q2 2026.
  • Medpace made up 0.06% of Atlas Capital Advisors's portfolio in Q2 2026, its #249 holding.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.